Arena Pharmaceuticals (ARNA)
$45.43
0.86 (1.85%)
ARNA Stock Quote Delayed 15 Minutes
Previous Close
$46.28
Market Cap
2.24B
PE Ratio
-16.52
EPS
-2.75
Volume (Avg. Vol.)
378,599
Day's Range
44.66 - 46.20
52-Week Range
31.97 - 64.48
Dividend & Yield
N/A (N/A)
ARNA Stock Predictions, Articles, and Arena Pharmaceuticals News
Don’t Get Trapped by All the Hype Surrounding Cronos Stock
The big rally from Cronos Group stock has stalled, but too many investors are certain it's just a breather before another leg higher.
Why Arena Pharmaceuticals Stock Is Soaring Today
Arena Pharmaceuticals stock was soaring Thursday on news of a license deal with United Therapeutics (UTHR) for ralinepag.
Intercept Pharmaceuticals Inc (ICPT) Stock Dives on Drug Warning
Intercept Pharmaceuticals (ICPT) stock took a hit on Tuesday following the release of a drug warning concerning its Ocaliva.
3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Barracuda Networks Inc (CUDA) and Arena Pharmaceuticals, Inc. (ARNA)
Snap (SNAP) continues slumping below its IPO price Tuesday and Arena Pharmaceuticals (ARNA) rockets ahead on trial data, while Barracuda Networks (CUDA) slides on earnings.
5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio
VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must
3 Stocks to Watch on Wednesday: Bank of America Corp (BAC), Arena Pharmaceuticals, Inc. (ARNA) and Fogo De Chao Inc (FOGO)
Bank of America (BAC) anxiously awaits a Fed decision on Wednesday, Arena Pharmaceuticals (ARNA) rockets higher and Fogo de Chao (FOGO) carves out some gains.
26 Biotechnology Stocks to Sell Now
The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
23 Biotechnology Stocks to Sell Now
The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
22 Biotechnology Stocks to Sell Now
This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
19 Biotechnology Stocks to Sell Now
The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Stocks to Watch on Friday: Arena Pharmaceuticals, Inc. (ARNA), Micron Technology, Inc. (MU) and Tesla Motors Inc (TSLA)
Tesla (TSLA) shares fell on a self-driving accident, Arena Pharmaceuticals (ARNA) will cut more than half its workforce and Micron (MU) misses revenue estimates.
Hottest Manufacturing Stocks Now – SID BDSI DGLY SPU
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
A Look at My Most Prescient Stock Picks for 2015
Finding the best stocks to buy is a never-ending quest. Looking back on my 2015 predictions, I found a handful of really good ones.
Hottest Healthcare Stocks Now – ISRG MD FOLD ALXN
Healthcare stocks finished down on Wall Street today, down 0.4%.
Hottest Healthcare Stocks Now – ELGX RGEN MASI AMED
Healthcare stocks finished up 0.2% on Wall Street today.
Hottest Healthcare Stocks Now – PTCT CELG ARNA CLDX
Healthcare stocks rose 0.7% on Wall Street so far on Wednesday.
Biggest Movers in Healthcare Stocks Now – ZLTQ EW ICLR HALO
Healthcare stocks rose broadly on Wall Street on Monday, with the sector seeing an overall increase of 0.9%.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
